Clinical trial
A Randomized Multi-centre Double-blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders
NCT03087201 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Multi-centre Double-blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders
- Lead sponsor
- Hannover Medical School
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 5, 2018
- Completion date
- November 20, 2020
- Enrollment
- 98 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.